ArticleMolecular cancer research : MCR2023

MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production.

Marlene Langenbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.